Recorded and downloadable computer software for real-time monitoring, managing, organizing, configuring, analyzing, prioritizing, optimizing, and control of computer networks, telecommunications networks, and satellite networks; Recorded and downloadable cloud computing software featuring artificial intelligence for improving and optimizing computer networks, internet, and telecommunications network connectivity and bandwidth; Recorded and downloadable cloud computing software featuring artificial intelligence for maintaining and improving network security and enforcement, enhancing network and security functionality and performance, scoring user experience of wireless network, application performance scoring, and managing and collecting data from telecommunications and computer networks; Downloadable software in the nature of a mobile application featuring artificial intelligence for monitoring, managing, organizing, configuring, analyzing, securing, optimizing, and control of computer networks, computer network information and data, telecommunications networks, and connectivity to computer networks and wireless devices;

Software as a service (SAAS), Platform as a service (PAAS), and Infrastructure as a Service (IAAS) featuring artificial intelligence software for real-time monitoring, managing, organizing, configuring, analyzing, prioritizing, securing, optimizing, control, and integration of computer networks, telecommunications networks, satellite networks, information technology infrastructure, and computer network information; Software as a service (SaaS) services, namely, hosting software for use by others in connection with enhancing application performance for computer network and telecommunications network deployments, network security monitoring and enforcement, network latency mitigation, and data reduction; Providing temporary use of non-downloadable cloud-based software for monitoring data centers, server availability, server and network connectivity, signal strength, congestion, computer network and wireless device status, network latency, network loss, and network jitter; technical support services, namely, providing installation, maintenance, troubleshooting, repair and monitoring of computer software; Providing on-line non-downloadable computer software for monitoring, managing, organizing, configuring, analyzing, prioritizing, securing, optimizing, and control of information technology infrastructure and computer network information; Providing temporary use of non-downloadable cloud-based software featuring artificial intelligence for real-time monitoring, managing, securing and collecting data from computer networks and telecommunications networks, network security monitoring and enforcement, measuring and scoring user experience of wireless network, and application performance scoring.

Camcorders; computer monitors; door alarms; electronic door locks; video recorders; video telephones

Pharmaceutical preparations; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of tumours.

Préparations pharmaceutiques destinées à la prévention ou au traitement des maladies cardiovasculaires, de l'hypertension, des hémorragies cérébrales et leurs séquelles, des maladies rénales, des maladies pulmonaires, des maladies fibrotiques, de la mucoviscidose, des maladies inflammatoires, des maladies allergiques, des maladies et troubles auto-immunes, des maladies et troubles neurodégénératifs, des maladies et troubles neurologiques, des maladies et troubles du système nerveux central, de la démence, de l'insomnie, des troubles anxieux, des addictions, des troubles des conduites alimentaires, de l'épilepsie, des troubles du métabolisme, du diabète, des maladies du stockage des glycolipides, de la maladie de Fabry et des symptômes et conséquences de la maladie de Fabry, maladies infectieuses et cancer.

Pharmaceutical preparations for the prevention or treatment of inflammatory diseases and inflammatory autoimmune disorders, namely chronic rhinosinusitis, asthma, chronic obstructive pulmonary disorder, atherosclerosis, myocarditis, sarcoidosis, inflammatory demyelinating diseases, multiple sclerosis, Guillain Barré syndrome, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, lupus nephritis, and auto-immune encephalomyelitis; pharmaceutical preparations for the prevention or treatment of neurodegenerative diseases and disorders, namely Alzheimer's disease, Lewy body dementia, Parkinson's disease, vascular dementia, subcortical dementia, frontotemporal dementia, multi-infarct dementia, arteriosclerotic dementia, and Huntington's disease; pharmaceutical preparations for the prevention or treatment of neuropsychiatric symptoms in dementia, namely agitation associated with dementia, aggression associated with dementia, confusion associated with dementia, and sundown syndrome; pharmaceutical preparations for the prevention or treatment of sleep disorders, namely dyssomnias, parasomnias, insomnias, primary insomnia, idiopathic insomnia, chronic insomnia, situational transient insomnias, insomnias associated with depressive disorders, epilepsy, autism spectrum disorders, attention deficit hyperactivity disorder (ADHD), or Alzheimer's disease, sleep apnea syndrome, periodic limb movement disorder, restless leg syndrome, circadian rhythm sleep disorders, time-zone-change syndrome, REM sleep interruptions, nightmare disorder, sleep terror disorder, and sleepwalking disorder; pharmaceutical preparations for the prevention or treatment of physical and psychological addictions, namely gambling addictions, internet addictions, eating addictions, nicotine addictions, and drug addictions; pharmaceutical preparations for the prevention or treatment of anxieties, namely generalized anxiety disorders (GAD), obsessive compulsive disorders (OCDs), acute stress disorders, posttraumatic stress disorders (PTSDs), panic anxiety disorders (PADs), avoidance, and somatoform disorders; pharmaceutical preparations for the prevention or treatment of metabolic disorders, namely polydipsias, anorexias, compulsive eating disorders, obesity, bulimias, cachexia, and binge eating disorder; pharmaceutical preparations for the prevention or treatment of mood disorders, namely depressive disorders, major depressive episode, manic episode, mixed episode and hypomanic episode, dysthymic disorders, bipolar disorders, and cyclothymic disorder; pharmaceutical preparations for the prevention or treatment of epilepsy; pharmaceutical preparations for the prevention or treatment of pain, namely neuropathic pain; pharmaceutical preparations for the prevention or treatment of cerebrovascular accident, and stroke; pharmaceutical preparations for the prevention or treatment of nausea.

Pharmaceutical preparations for the prevention or treatment of inflammatory diseases and inflammatory autoimmune disorders, namely chronic rhinosinusitis, asthma, chronic obstructive pulmonary disorder, atherosclerosis, myocarditis, sarcoidosis, inflammatory demyelinating diseases, multiple sclerosis, Guillain Barré syndrome, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, lupus nephritis, and auto-immune encephalomyelitis; pharmaceutical preparations for the prevention or treatment of neurodegenerative diseases and disorders, namely Alzheimer's disease, Lewy body dementia, Parkinson's disease, vascular dementia, subcortical dementia, frontotemporal dementia, multi-infarct dementia, arteriosclerotic dementia, and Huntington's disease; pharmaceutical preparations for the prevention or treatment of neuropsychiatric symptoms in dementia, namely agitation associated with dementia, aggression associated with dementia, confusion associated with dementia, and sundown syndrome; pharmaceutical preparations for the prevention or treatment of sleep disorders, namely dyssomnias, parasomnias, insomnias, primary insomnia, idiopathic insomnia, chronic insomnia, situational transient insomnias, insomnias associated with depressive disorders, epilepsy, autism spectrum disorders, attention deficit hyperactivity disorder (ADHD), or Alzheimer's disease, sleep apnea syndrome, periodic limb movement disorder, restless leg syndrome, circadian rhythm sleep disorders, time-zone-change syndrome, REM sleep interruptions, nightmare disorder, sleep terror disorder, and sleepwalking disorder; pharmaceutical preparations for the prevention or treatment of physical and psychological addictions, namely gambling addictions, internet addictions, eating addictions, nicotine addictions, and drug addictions; pharmaceutical preparations for the prevention or treatment of anxieties, namely generalized anxiety disorders (GAD), obsessive compulsive disorders (OCDs), acute stress disorders, posttraumatic stress disorders (PTSDs), panic anxiety disorders (PADs), avoidance, and somatoform disorders; pharmaceutical preparations for the prevention or treatment of metabolic disorders, namely polydipsias, anorexias, compulsive eating disorders, obesity, bulimias, cachexia, and binge eating disorder; pharmaceutical preparations for the prevention or treatment of mood disorders, namely depressive disorders, major depressive episode, manic episode, mixed episode and hypomanic episode, dysthymic disorders, bipolar disorders, and cyclothymic disorder; pharmaceutical preparations for the prevention or treatment of epilepsy; pharmaceutical preparations for the prevention or treatment of pain, namely neuropathic pain; pharmaceutical preparations for the prevention or treatment of cerebrovascular accident, and stroke; pharmaceutical preparations for the prevention or treatment of nausea.

Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; Pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; Pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; Pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; Pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of muscular dystrophy

Cell and gene therapy services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents.

Business and publishing services, namely, digital conversion, preparation, composition, distribution, display and fulfillment services in the field of Internet and electronic media publications and distribution.

Thematic portals which aggregate proprietary and syndicated content for wireless operator networks.

Wireless telecommunication services, namely providing software and hardware enabling wireless operators to access thematic portals.